The Texas Division of Emergency Management has launched more than 20 COVID-19 antibody infusion centers across the state since August. The newest opened two days ago in the Texarkana suburb of Nash, which will help the stress on hospitals by treating mild and moderate COVID-19 cases.
The centers use a treatment from the pharmaceutical company Regeneron, which is a solution of two lab-made antibodies that boost the body鈥檚 ability to fight infection.
Regeneron's treatment, , helps decrease the severity and length of symptoms, which include difficulty breathing, loss of taste and smell, and fever. It also reduced the need for hospitalization by around 70%.
The FDA back in August for treatment in people 12 and older who had come into contact with the virus.
It鈥檚 not meant to be a preventive measure used to protect people from becoming exposed to the virus or to treat people with severe cases of COVID.
The infusion centers are a key part of Gov. Greg Abbott鈥檚 approach to navigating the coronavirus surge that hit Texas in July and finally has slowed in recent weeks. He said in a press release in mid-August that the centers would 鈥�.鈥�
But, over the past few months, cases and hospitalizations have skyrocketed across the state, including an increase in cases among children since school started. More than 154,000 children have been infected with COVID-19 since Aug. 8, . Hospitals, especially pediatric hospitals, have seen record numbers of patients in the ER with the virus. for Dallas County still top over 1,000, although that鈥檚 down from an earlier peak a few weeks back.
While the infusion centers will provide immunity support for people who have been exposed to the virus, both the FDA and the CDC report these treatments are .
In North Texas, there are public facilities in Fort Worth, McKinney and Nash, plus other private locations .
Got a tip? Email Elena Rivera at erivera@kera.org. You can follow Elena on Twitter .
四虎影院 is made possible through the generosity of our members. If you find this reporting valuable, consider Thank you.
